Organ Selective Delivery Using a Tissue-Directed Sreptavidin-Biotin System: Targeting 5-Fluorouridine via TNP-Streptavidin

References

• Argarana C. E., Kuntz I. D., Birken S., Axel R., Cantor C. R. Molecular cloning and nucleotide sequence of the streptavidin gene. Nucleic Acid Res. 1986; 14: 1871–1882
   PubMed Web of Science ®Google Scholar
• Ashwell G., Harford J. Carbohydrate specific receptors in the liver. Annu Rev Biochem. 1982; 51: 531–544
   PubMed Web of Science ®Google Scholar
• Chaiet L., Wolf F. J. The properties of streptavidin, a biotin-binding protein produced by streptomyces. Arch. Biochem. Biophys. 1964; 106: 1–5
   PubMed Web of Science ®Google Scholar
• Dahlgren C., Sundqvist T. Phagocytosis and hydrophobicity: a method of calculating contact angles based on the diameter of sessil drops. J. Immunol. Method 1981; 40: 171–175
   PubMed Web of Science ®Google Scholar
• Edebo L., Richardson N. Enhancement of hydrophobic interaction, negative charge and phagocytosis by dinitrophenyl ligand coupling to Salmonella typhimurium 395 MS. Int. Arch. Allergy Appl. Immunol. 1985; 78: 345–352
   PubMedGoogle Scholar
• Ellison D., Hinton J., Hubbard S. J., Beynon R. J. Limited proteolysis of native proteins: The interaction between avidin and proteinase K. Protein Science 1995; 4: 1337–1345
   PubMed Web of Science ®Google Scholar
• Friedrich E. A., Aulenbacher P., Schlepper J., Suss R. Kupffer cells recognize trinitrobenzene-labeled erythrocytes. Immunology Letters 1982; 4: 167–170
   PubMed Web of Science ®Google Scholar
• Green N. M. Avidin. Advances in Protein Chemistry, C. B. Anfinsen, J. T. Edsal, F. M. Richard. Academic Press, New York 1975; 29: 85–133
   Google Scholar
• Haberland M. E., Fogelman A. M. Scavenger receptor-mediated recognition of maleyl bovine plasma albumin and the demaleylated protein in human monocytes macrophages. Proc. Natl. Acad. Sci. USA 1985; 82: 2693–2697
   PubMed Web of Science ®Google Scholar
• Heuff G., Oldenburg H. S., Boutkan H., et al. Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells. Cancer Immunol. Immunother. 1993; 37: 125–130
   Google Scholar
• Hiller Y., Bayer E. A., Wilchek M. Studies on the biotin-binding site of avidin. Biochem. J. 1991; 278: 573–585
   PubMed Web of Science ®Google Scholar
• Hunter W. M., Greenwood F. C. Preparation of iodine-131 labeled growth hormone of high specific activity. Nature (Land) 1962; 194: 595–596
   Web of Science ®Google Scholar
• Hurwitz E., Wilchek M., Pitha J. Soluble macromolecules as carriers for daunorubicin. J. Applied Biochem. 1980; 2: 25–35
   Google Scholar
• Hurwitz E., Kashi R., Arnon R., Wilchek M., Sela M. The covalent linkage of two nucleotide analogues to antibodies. J. Medicinal Chem. 1985; 28: 137–140
   PubMed Web of Science ®Google Scholar
• Hurwitz E., Stancovski I., Wilchek M., Shouval D., Takahashi H., Wands J. R., Sela M. A conjugate of 5-fluorouridine-poly(L-lysine) and an antibody reactive with human colon carcinoma. Bioconjugate Chem. 1990; 1: 285–290
   PubMed Web of Science ®Google Scholar
• Maack T., Johnson V., Kau S. T., Figuereido J., Sigulem D. Renal filtration, transport and metabolism of low molecular weight proteins: a review. Kidney Int. 1979; 16: 251–270
   PubMed Web of Science ®Google Scholar
• McCuskey P., Kan Z., Wallace S. An electron microscopy study of Kupffer cells in livers of mice having Friend erythroleukemia hepatic metastases. Hepatology 1995; 21: 487–494
   PubMedGoogle Scholar
• Meterissian S., Steele G. D., Jr, Thomas P. Human and murine Kupffer cell function may be altered by both intrahepatic and intrasplenic tumor deposits. Clin. Exp. Metastasis 1993; 11: 175–182
   PubMed Web of Science ®Google Scholar
• Miron T., Carter W. G., Wilchek M. Polyacrylhydrazido-agarose as a support for immobilization of enzymes, lectins, antibodies and ligands. J. Solid Phase Biochemistry 1976; 1: 225–236
   Google Scholar
• Neurath R., Debnath A. K., Strick N., Li Y. Y., Lin K., Jiang S. Blocking of CD4 cell receptors for human immunodeficiency virus type 1 (HIV-1) by chemically modified bovine milk proteins: Potential for AIDS prophylaxis. J. Molec. Recog. 1995; 8: 304–316
   PubMed Web of Science ®Google Scholar
• Pasqualini R., Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 1996; 380: 364–366
   PubMed Web of Science ®Google Scholar
• Pasqualini R., Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998; 279: 377–380
   PubMed Web of Science ®Google Scholar
• Schechter B., Silberman R., Arnon R., Wilchek M. Tissue distribution of avidin and streptavidin injected to mice. Eur. J. Biochem. 1990; 462: 327–331
   Google Scholar
• Schechter B., Arnon R., Wilchek M., Schlessinger J., Hurwitz E., Aboud-Pirak E., Sela M. Indirect immunotargeting of cis-Pt to human epidermoid carcinoma KB using the avidin-biotin system. Int. J. Cancer 1991; 48: 243–256
   Web of Science ®Google Scholar
• Schechter B., Arnon R., Colas C., Burakova T., Wilcheck M. Renal accumulation of streptavidin: Potential use for targeted therapy to the kidney. Kidney Int. 1995; 47: 1327–1335
   PubMed Web of Science ®Google Scholar
• Schechter B., Arnon R., Freedman Y. E., Chen L., Wilchek M. Liver accumulation of TNP-modified streptavidin and avidin: Potential use for targeted radio- and chemotherapy. J. Drug Targeting 1996; 4: 171–179
   PubMed Web of Science ®Google Scholar
• Smolyanskaya A. Z., Trigarinov O. A. The biological activity of anti-tumor antimetabolite “Ftorafur”. Neoplasma 1972; 19: 341–345
   PubMed Web of Science ®Google Scholar
• Skogh T., Stendahl O., Sundqvist T., Edebo L. Physicochemical properties and blood clearance of human serum albumin conjugated to different extents with dinitrophenyl groups. Int. Arch. Allergy Appl. Immunol. 1983; 70: 238–244
   PubMedGoogle Scholar
• Takakura T., Fujita T., Furitsu H., et al. Pharmacokinetics of succinylated proteins and dextran sulfate in mice: Implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors. Int. J. Pharmacol. 1994; 105: 19–29
   Google Scholar
• Taylor M. E., Bezouska K., Drickamer K. Contribution to ligand binding by multiple carbohydrate-recognition domain in the macrophage mannose receptor. J. Biol. Chem. 1992; 267: 1719–1726
   PubMed Web of Science ®Google Scholar
• Valdivieso M., Bodey G. P., Gottlieb J. A., Freirei E. J. Clinical evaluation of ftorafur (pyrimidine-deoxyribose N1-2'-furanidyl-5-fluorouracil). Cancer Res. 1976; 36: 1821–1824
   PubMed Web of Science ®Google Scholar
• Van Borssum Waalkes M., Scherphof G. L. Liposome-incorporated 3',5'-O-dipalmitol-5-fluoro-2'-deoxyuridine as a slow-release anti-tumor drug depot in rat liver macrophages. Sel. Cancer Ther. 1990; 6: 15–22
   PubMedGoogle Scholar
• Van Groeningen C. J., Pinedo H. M., Heddes, et al. Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule. Cancer Res. 1988; 48: 6956–6961
   PubMed Web of Science ®Google Scholar
• Van Oss C. J. Phagocytosis as a surface phenomenon. Ann. Res. Microbiol. 1978; 32: 19–23
   PubMed Web of Science ®Google Scholar
• Yonei Y., Kurse I., Fukumura D., Saito H., Tsukada N., Oda M., Tsuchiya M. Evidence of direct interaction between Kupffer cells and colon cancer: an ultrastructural study of the co-culture. Liver 1994; 14: 37–44
   PubMedGoogle Scholar